-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Upgrades Bioage Labs to Equal-Weight, Raises Price Target to $12

Benzinga·12/08/2025 17:07:25
Listen to the news
Morgan Stanley analyst Jeffrey Hung upgrades Bioage Labs (NASDAQ:BIOA) from Underweight to Equal-Weight and raises the price target from $5 to $12.